Udviklingen af HACA var ikke forbundet med klinisk forværring eller øget risiko for reaktioner ved efterfølgende infusioner hos hovedparten af disse patienter.
The emergence of HACA was not associated with clinical deterioration or with an increased risk of reactions to subsequent infusions in the majority of patients.